Terms: = Leukemia AND TRIM24, O15164, 8805, ENSG00000122779, TIF1ALPHA, TF1A, TIF1A, hTIF1, Tif1a, TIF1, RNF82, PTC6 AND Prognosis
3 results:
1. Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual trim24-BRPF1 Bromodomain Inhibitor.
Palmer WS; Poncet-Montange G; Liu G; Petrocchi A; Reyna N; Subramanian G; Theroff J; Yau A; Kost-Alimova M; Bardenhagen JP; Leo E; Shepard HE; Tieu TN; Shi X; Zhan Y; Zhao S; Barton MC; Draetta G; Toniatti C; Jones P; Geck Do M; Andersen JN
J Med Chem; 2016 Feb; 59(4):1440-54. PubMed ID: 26061247
[TBL] [Abstract] [Full Text] [Related]
2. Reverse phase protein array profiling reveals distinct proteomic signatures associated with chronic myeloid leukemia progression and with chronic phase in the CD34-positive compartment.
Quintás-Cardama A; Qiu YH; Post SM; Zhang Y; Creighton CJ; Cortes J; Kornblau SM
Cancer; 2012 Nov; 118(21):5283-92. PubMed ID: 22517119
[TBL] [Abstract] [Full Text] [Related]
3. Biallelic IgH rearrangements in patients with indolent lymphoproliferative disorders: molecular and practical implications.
Cerny J; Slavickova A; Krepelova A; Trneny M; Karban J; Klener P
J Cell Physiol; 2004 May; 199(2):217-26. PubMed ID: 15040004
[TBL] [Abstract] [Full Text] [Related]
